NJSの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/05/18 | 1,399 | 1,402 | 1,390 | 1,399 | -3 | -0.2% | 7,700 |
2017/05/17 | 1,393 | 1,406 | 1,393 | 1,402 | -1 | -0.1% | 4,600 |
2017/05/16 | 1,393 | 1,403 | 1,393 | 1,403 | +8 | +0.6% | 6,700 |
2017/05/15 | 1,390 | 1,403 | 1,390 | 1,395 | +5 | +0.4% | 6,600 |
2017/05/12 | 1,380 | 1,393 | 1,374 | 1,390 | +10 | +0.7% | 6,300 |
2017/05/11 | 1,370 | 1,385 | 1,369 | 1,380 | -7 | -0.5% | 8,100 |
2017/05/10 | 1,385 | 1,392 | 1,381 | 1,387 | -6 | -0.4% | 8,000 |
2017/05/09 | 1,395 | 1,395 | 1,385 | 1,393 | -1 | -0.1% | 6,600 |
2017/05/08 | 1,385 | 1,396 | 1,384 | 1,394 | +17 | +1.2% | 10,500 |
2017/05/02 | 1,381 | 1,390 | 1,377 | 1,377 | -4 | -0.3% | 6,700 |
2017/05/01 | 1,381 | 1,381 | 1,373 | 1,381 | +6 | +0.4% | 3,300 |
2017/04/28 | 1,386 | 1,386 | 1,375 | 1,375 | -11 | -0.8% | 3,000 |
2017/04/27 | 1,392 | 1,392 | 1,378 | 1,386 | +1 | +0.1% | 5,300 |
2017/04/26 | 1,388 | 1,389 | 1,379 | 1,385 | +2 | +0.1% | 4,200 |
2017/04/25 | 1,378 | 1,387 | 1,374 | 1,383 | +25 | +1.8% | 12,000 |
2017/04/24 | 1,348 | 1,360 | 1,347 | 1,358 | +10 | +0.7% | 5,500 |
2017/04/21 | 1,341 | 1,350 | 1,334 | 1,348 | +10 | +0.7% | 6,800 |
2017/04/20 | 1,338 | 1,344 | 1,337 | 1,338 | ±0 | ±0% | 4,500 |
2017/04/19 | 1,339 | 1,345 | 1,334 | 1,338 | +4 | +0.3% | 7,900 |
2017/04/18 | 1,346 | 1,346 | 1,334 | 1,334 | +8 | +0.6% | 3,900 |
2017/04/17 | 1,316 | 1,336 | 1,316 | 1,326 | +10 | +0.8% | 3,700 |
2017/04/14 | 1,306 | 1,390 | 1,301 | 1,316 | +10 | +0.8% | 19,000 |
2017/04/13 | 1,300 | 1,312 | 1,300 | 1,306 | ±0 | ±0% | 8,400 |
2017/04/12 | 1,325 | 1,325 | 1,301 | 1,306 | -19 | -1.4% | 14,600 |
2017/04/11 | 1,321 | 1,334 | 1,313 | 1,325 | +4 | +0.3% | 6,100 |
2017/04/10 | 1,307 | 1,331 | 1,307 | 1,321 | +3 | +0.2% | 5,400 |
2017/04/07 | 1,328 | 1,330 | 1,315 | 1,318 | +8 | +0.6% | 7,500 |
2017/04/06 | 1,333 | 1,333 | 1,310 | 1,310 | -15 | -1.1% | 8,900 |
2017/04/05 | 1,326 | 1,331 | 1,325 | 1,325 | ±0 | ±0% | 3,400 |
2017/04/04 | 1,325 | 1,335 | 1,312 | 1,325 | -2 | -0.2% | 8,800 |
2017/04/03 | 1,340 | 1,340 | 1,325 | 1,327 | -13 | -1% | 9,400 |
2017/03/31 | 1,370 | 1,370 | 1,340 | 1,340 | -16 | -1.2% | 5,000 |
2017/03/30 | 1,377 | 1,377 | 1,349 | 1,356 | -17 | -1.2% | 8,500 |
2017/03/29 | 1,349 | 1,381 | 1,340 | 1,373 | +18 | +1.3% | 10,000 |
2017/03/28 | 1,350 | 1,364 | 1,329 | 1,355 | +5 | +0.4% | 13,000 |
2017/03/27 | 1,338 | 1,354 | 1,332 | 1,350 | +2 | +0.1% | 12,500 |
2017/03/24 | 1,348 | 1,374 | 1,336 | 1,348 | +14 | +1% | 7,400 |
2017/03/23 | 1,316 | 1,356 | 1,312 | 1,334 | ±0 | ±0% | 7,900 |
2017/03/22 | 1,365 | 1,366 | 1,301 | 1,334 | -33 | -2.4% | 21,600 |
2017/03/21 | 1,373 | 1,380 | 1,350 | 1,367 | ±0 | ±0% | 10,700 |
2017/03/17 | 1,370 | 1,380 | 1,367 | 1,367 | -24 | -1.7% | 2,500 |
2017/03/16 | 1,393 | 1,400 | 1,360 | 1,391 | +28 | +2.1% | 21,800 |
2017/03/15 | 1,399 | 1,399 | 1,341 | 1,363 | -36 | -2.6% | 12,000 |
2017/03/14 | 1,421 | 1,421 | 1,386 | 1,399 | -30 | -2.1% | 10,500 |
2017/03/13 | 1,425 | 1,434 | 1,413 | 1,429 | -6 | -0.4% | 10,100 |
2017/03/10 | 1,430 | 1,435 | 1,427 | 1,435 | +12 | +0.8% | 10,400 |
2017/03/09 | 1,425 | 1,427 | 1,423 | 1,423 | -2 | -0.1% | 1,700 |
2017/03/08 | 1,419 | 1,425 | 1,412 | 1,425 | +13 | +0.9% | 3,100 |
2017/03/07 | 1,409 | 1,418 | 1,409 | 1,412 | -6 | -0.4% | 2,900 |
2017/03/06 | 1,400 | 1,429 | 1,397 | 1,418 | -12 | -0.8% | 5,700 |
1801~
1850
件表示中 / 5390件
類似銘柄と比較する
現在ご覧いただいている「NJS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
NJS | 350,000円 | +2.2% | +73.1% | 2.71% | 15.86倍 | 1.25倍 |
|
上下水道のコンサルタント。官公需がほとんど。調査から設計・施工監理まで一貫。海外拠点多数 |
WDB | 175,900円 | +5.1% | -13.4% | 3.44% | 11.63倍 | 1.15倍 |
|
理学系研究職や研究補助職の人材派遣で首位。医薬品開発受託(CRO)や医薬関連事務も |
ITM | 167,300円 | +7.9% | +3.1% | 5.98% | 20.79倍 | 3.31倍 |
|
IT系ネットメディア運営。各種広告展開。営業見込み客情報提供するリードジェンを強化中 |
クリーク&リバ | 150,800円 | +10.4% | +16.0% | 2.85% | 10.29倍 | 2.05倍 |
|
テレビ・ゲーム・Web・広告等の派遣、制作が主。医療ほか専門職分野拡大。配当性向30%メド |
アイロムG | 278,500円 | - | - | - | - | 2.64倍 |
|
SMO(医療機関向け治験支援)主力。日・豪でCRO(医薬品開発受託)。MBO実施準備 |
市場注目の銘柄
チャート関連のコラム